SLIT2 and central nervous system cancer: Following these original observations, recent studies employing murine GBM models [46] or patient-derived tumor spheres and xenograft models [43] demonstrate contradictory results, with the increased expression of Slit2 in gliomas being correlated with tumor progression and invasiveness [7].